References
- Tzellos T, Zouboulis CC, Gulliver W, et al. Impact of hidradenitis suppurativa on work productivity. Br J Dermatol. 2019;181:758–765.
- Marzano AV, Genovese G, Moltrasio C, et al. Unemployment in hidradenitis suppurativa: cumulative life-course impairment. Dermatology. 2024;240:181–188.
- Kouris A, Platsidaki E, Christodoulou C, et al. Quality of life and psychosocial aspects in hidradenitis suppurativa. Dermatology. 2016;232:687–691.
- Friedman AJ, Kirby JS. Impact of hidradenitis suppurativa on employment. Br J Dermatol. 2023;188:9–10.
- Jemec GBE. Clinical practice. Hidradenitis suppurativa. N Engl J Med. 2012;366:158–164.
- Ingram JR, Collier F, Brown D, et al. BAD guidelines for the management of hidradenitis suppurativa. Br J Dermatol. 2019;181:76–90.
- Revuz JE. Hidradenitis suppurativa: a severe disease with substantial social burden. J Am Acad Dermatol. 2009;60:S33–S36.
- Friedman AJ, Kirby JS. Professional life impact in hidradenitis suppurativa. Br J Dermatol. 2023;188:122–130.
- Garg A, Kirby JS, Lavian J, Lin G, Strunk A. Work loss, indirect costs and income in hidradenitis suppurativa. Br J Dermatol. 2020;183:758–764.
- Patel ZS, Hoffman LK, Buse DC, et al. Pain and psychological comorbidities in hidradenitis suppurativa. Curr Pain Headache Rep. 2020;24:1–7.
- Sano A, Yagami A, Suzuki K, et al. Two Cases of Occupational Contact Urticaria Caused by Percutaneous Sensitization to Parvalbumin. Case Rep Dermatol. 2015 Aug 29;7(2):227-32. doi: 10.1159/000439080. Erratum in: Case Rep Dermatol. 2015 Nov 11;7(3):328.
- Casseres RG, Prussick L, Cohen SR. Management of hidradenitis suppurativa in the workplace. Clin Cosmet Investig Dermatol. 2023;16:1–7.